The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|6|770-779

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.6, 2015-05, pp. : 770-779

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular characterization of the equine ATP2A2 gene

By  

Cytogenetic and Genome Research, Vol. 116, Iss. 4, 2007-04 ,pp. : 256-262

Karger

Access to resources Recommend Favorite

MDS clinical diagnostic criteria for Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 12, 2015-10 ,pp. : 1591-1601

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical features of familial Parkinson's disease in Thai patients

By Prueksaritanond Somjit   Boongird Prasert   Pulkes Teeratorn   Prueksaritanond Suartcha  

Quality in Primary Care, Vol. 17, Iss. 2, 2009-04 ,pp. : 115-122

Radcliffe Press

Access to resources Recommend Favorite

DEVELOPMENT OF A CLINICAL RATING SCALE FOR PERSONS WITH PARKINSON'S DISEASE

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 47, Iss. 6, 1999-06 ,pp. : 763-764

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gut microbiota are related to Parkinson's disease and clinical phenotype

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 3, 2015-03 ,pp. : 350-358

John Wiley & Sons Inc

Access to resources Recommend Favorite